Reviewer
variis Editorial Desk
[Reviewer Name], Editor of record, variis
Placeholder reviewer entry. Replace with the named human accountable for medical content on variis.
What variis Editorial Desk has signed off on
Two rounds, one IPO: how Singapore and Australia are funding longevity in 2025 to 2026
Across eighteen months, the region's longevity capital has taken three distinct shapes: a Melbourne clinic's seed to Series A climb, a Singapore drug discovery company's Hong Kong listing, and a five year commitment to build a flagship clinic from scratch. Together they sketch what type of longevity business Singapore and Australia capital is actually prepared to back.
Singapore pushes clinical longevity care into the mainstream
From Chi Longevity's precision health model to a new Geromedicine Conference at NUS, Singapore is positioning itself as a hub for translating longevity science into real-world clinical practice.
Can longevity be designed for everyone, not just the wealthy?
Morrow's founders argue that longevity care can move beyond elite clinics through lifestyle medicine and AI-powered approaches.
NUS launches healthy longevity graduate certificate
The National University of Singapore has introduced what it describes as the world's first postgraduate program combining geroscience, gerodiagnostics and precision geromedicine in a single curriculum.
New trial to test precision geromedicine for healthy ageing
The PROMETHEUS study will examine tailored lifestyle, supplement, and drug approaches to counter age-related disease as global populations age.
GLP-1s and healthspan: a 2026 reader’s primer
Oral GLP-1s arrived in force in 2026. What the evidence supports , and what it does not.
Every article on variis carries a named reviewer. See our editorial standards for the review process.